What Orchard Therapeutics plc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Geraghty James A | Director | Jan 24 | Disposition to Issuer · D | −44,391 | — | — | 0 |
| Thomas Frank E | See Remarks | Jan 24 | Disposition to Issuer · D | −92,081 | — | — | 0 |
| Gaspar Bobby | Chief Executive Officer | Jan 24 | Disposition to Issuer · D | −366,158 | — | — | 0 |
| Dunoyer Marc | Director | Jan 24 | Disposition to Issuer · D | −37,179 | — | — | 0 |
| Beck Joanne T. | Director | Jan 24 | Disposition to Issuer · D | −9,294 | — | — | 0 |
| Rowland Charles A Jr | Director | Jan 24 | Disposition to Issuer · D | −12,294 | — | — | 0 |
| Thomas Frank E | See Remarks | Mar 10 | Exercise / conversion · M | +20,000 | $0.46 | +$9.18K | 92,081 |
| Thomas Frank E | See Remarks | Feb 09 | Exercise / conversion · M | +20,000 | $0.46 | +$9.18K | 72,081 |
| Thomas Frank E | See Remarks | Apr 01 | Open-market buy · P | +10,000 | $0.75 | +$7.47K | 52,081 |
| Gaspar Bobby | Chief Executive Officer | Apr 01 | Open-market buy · P | +15,000 | $0.74 | +$11.1K | 366,158 |
| Fmr Llc | 10% owner | Feb 19 | Derivative Conversion · C | −409,852 | — | — | 4,099,540 |
| Fmr Llc | 10% owner | Feb 19 | Derivative Conversion · C | −409,852 | — | — | 4,099,540 |
| Fmr Llc | 10% owner | Feb 05 | Open-market sale · S | −1,022,755 | $6.98 | −$7.14M | 5,099,540 |
| Fmr Llc | 10% owner | Feb 05 | Open-market sale · S | −1,022,755 | $6.98 | −$7.14M | 5,099,540 |
| Thomas Frank E | See Remarks | Jan 29 | Exercise / conversion · M | +10,000 | $2.44 | +$24.4K | 42,081 |
| Thomas Frank E | See Remarks | Jan 11 | Withheld — tax / exercise cost · F | −3,706 | $6.72 | −$24.9K | 32,081 |
| Gaspar Bobby | Chief Executive Officer | Jan 11 | Withheld — tax / exercise cost · F | −3,411 | $6.72 | −$22.9K | 351,158 |
| Thomas Frank E | See Remarks | Jan 08 | Grant / award · A | +10,667 | — | — | 35,787 |
| Gaspar Bobby | Chief Executive Officer | Jan 08 | Grant / award · A | +6,250 | — | — | 354,569 |
| Ra Capital MANAGEMENT, L.p. | 10% owner | Sep 24 | Open-market buy · P | +473,327 | $4.61 | +$2.18M | 9,880,865 |
Loading...